Two Cheshire life sciences firms are teaming up to launch a new service designed to enable innovative scientific research and accelerate their growth in the pharma and biotech sectors.
The collaboration between Cryoniss, which has facilities in Runcorn and at the Alderley Park bioscience campus near Macclesfield, and Daresbury-based Perfectus Biomed Group, strengthens the relationship between the two companies.
By expanding into cell culture services, which seek to ensure the integrity of data produced through research, Cryoniss – which was founded in 2018 – moves beyond biological sample storage and logistics.
Sonia Houghton, co-founder and CEO at Cryoniss, said: “This collaboration gives us the ability, for the first time, to support our customers with the generation of high-quality cell banks, providing them assurance that their cells are free from contaminants.
“We are now better equipped than ever to respond to our customers’ needs in an agile and responsive way and give them confidence that the samples they’re working with will produce excellent, reliable data.”
Samantha Westgate, CEO at Perfectus Biomed Group, added: “We have an excellent relationship with Cryoniss and it’s a pleasure to be collaborating on this latest project, leveraging the expertise that exists across the two businesses.”
Earlier this year Cryoniss announced that it was targeting accelerated growth after securing a £500,000 investment from NPIF – Maven Equity Finance, managed by Maven Capital Partners and part of the Northern Powerhouse Investment Fund (NPIF).
Perfectus Biomed Group, which provides both standard and customised microbiological testing services from its lab at Daresbury Science Park, celebrates its 10-year anniversary this year. In 2020 it merged with a laboratory based in Wyoming, US, expanding its service offering and geographical foothold.